$Zura Bio (ZURA.US)$Zura Bio Ltd: Tibulizumab (Zb-106) Was Well Tolerated and Neutralized Il-17a and Baff in a Phase 1 Study in Patients With Sjogren's Syndrome! Presents data at EULAR 2024
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more